BRANDON LIPSCOMB: Open Payments
NPI 1932518099 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 51 payments from 19 companies in 2025. Trend: 2023 $1,625 · 2024 $1,922 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $160 |
| Novo Nordisk Inc | 7 | $154 |
| ABBVIE INC. | 5 | $121 |
| Abbott Laboratories | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
| Lilly USA, LLC | 4 | $80 |
| Amgen Inc. | 3 | $43 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
Products named: NURTEC ODT, FREESTYLE LIBRE 3, TRINTELLIX, Wegovy, QULIPTA, MOUNJARO, UBRELVY, Ozempic.
Industry payments across VA — which companies pay providers there.
